lab equipment

Gerszten Lab

Investigating Personal Genomics and Cardiometabolic Disease

Gerszten Lab

Discovering Disease Before it Begins

The Gerszten Lab is a national leader in metabolomics and proteomics technologies. Among its key discoveries, the lab has identified novel biomarkers that single out individuals destined to develop diabetes and heart disease more than a decade before disease onset, with the goal of determining which of these patients might benefit from early clinical interventions.

Our Research

Latest News

Novel Biomarker and Pathway Discovery

The Gerszten Lab is taking a close look at molecular signs of disease with the goal of uncovering early risk factors and identifying high-risk individuals appropriate for preventive interventions.